SARS: responding to an unknown virus

Bio-safety and bio-security: A major global concern for ongoing COVID-19 pandemic

Besides its impacts on governance, economics, human culture, geostrategic partnership and environment, globalization greatly exerted control over science and security policies. Biosecurity is the critical job of efforts, policy and preparation to protect health of human, animal and environmental against any biological threats. With the transition into a global village, the possibility of biosecurity breaches has significantly increased. The COVID-19 pandemic is an example of an infringement on biosecurity that has posed a serious threat to the world. Since the first report on the recognition of COVID-19, a number of governments have taken preventive measures, like; lockdown, screening and early detection of suspected and implementing the required response to protect the loss of life and economy. Unfortunately, some of these measures have only recently been taken in some countries, which have contributed significantly to an increased morbidity and loss of life on a daily basis. In this article, the biological risks affecting human, animal and environmental conditions, biosafety violations and preventive measures have been discussed in order to reduce the outbreak and impacts of a pandemic like COVID-19.

Antiviral properties of chalcones and their synthetic derivatives: a mini review

Chalcones (natural or synthetic derivatives) are aromatic ketones possessing a central backbone that form a core for variety important compounds with different substitutions. Recent scientific advances show that chalcones exhibit different bio-medical activities, including antiviral, which is related to the variety substitutions. This review provides general information on the origin, sources, virucidal and direct antiviral properties of chalcones in vitro, as well as a brief overview of the possible application and molecular modes of action of these compounds. The antiviral effect of chalcones probably results from the disruption of the different stage of viral replication cycle, inhibition of viral or cell enzymes, induction of apoptosis and others. Structural requirements for antiviral activities vary according to the mechanisms of action. Based on the published information, it could be considered that synthetic chalcones are very perspective antiviral candidates and deserve further studies for elucidating of their pharmacological potential.

SARS in Singapore-challenges of a global health threat to local institutions

SARS (Severe Acute Respiratory Syndrome) has been declared by WHO (World Health Organisation) as a global health threat. Within a period of four to five months in 2003, the disease infected some 8,000 people in more than 25 countries and left 774 dead. The many studies that have been done on the spread of SARS in Asia as well as countries as far flung as Germany and Canada have focused on the global dimension of the infectious disease as well as the speed of its spread upon emergence in southern China and then Hong Kong. Less attention has been paid to its spatial distribution at the national and local scales. This discussion focuses on the spread of SARS at the national and local spatial scales. In the process, the study presents the management of a hazard, in this case, an emerging infectious disease by national health care institutions such as the hospitals that ultimately proved to have been wholly unprepared for coping with at least the health aspects of the outcome of a globalised national agenda for growth and economic progress.

Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase

In order to further the present knowledge of the emerging severe acute respiratory syndrome-associated coronavirus (SARS-CoV), 486 different specimens from 54 patients with a clinical diagnosis of SARS were investigated for the presence of viral RNA, and 314 plasma specimens of 73 patients were examined for IgM and IgG antibodies specific against SARS-CoV using an indirect ELISA. Viral RNA was detectable in 28 of the 54 patients tested. Cumulative data showed that 67 of the 73 SARS patients demonstrated seroconversion by week 5 of illness. In contrast, only 1 of 278 healthy subjects enrolled in the study was found to be positive for the IgG antibody. Coexistence of viral RNA in plasma and specific antibodies was simultaneously observed over three consecutive weeks in two critical cases. In three convalescent patients in particular, cultivable SARS-CoV was detected in stool or urine specimens for longer than 4 weeks (29-36 days). These findings suggest that SARS-CoV may remain viable in the excretions of convalescent patients.

Severe acute respiratory syndrome: responses of the healthcare system to a global epidemic

PURPOSE OF REVIEW

To evaluate recent developments in the response of the healthcare system to the threat of severe acute respiratory syndrome in the context of the Toronto experience.

RECENT FINDINGS

The severe acute respiratory syndrome outbreak affected over 8000 people killing 774 by July 2003. It particularly affected those providing health care. The initial response of the healthcare system was to use infection control techniques to prevent transmission to staff and patients. This had a dramatic impact on healthcare provision for non-severe acute respiratory syndrome patients during this period.

SUMMARY

The ongoing response to severe acute respiratory syndrome is continued effective infection control education, development of local and global policies for reacting to a severe acute respiratory syndrome-like outbreak in the future, and continued work on a vaccine for severe acute respiratory syndrome.